Skip to main content
Log in

ASO Author Reflections: Is Systemic Chemotherapy Useful in Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Colorectal Peritoneal Metastases? A Propensity Score Analysis

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Bushati M, Rovers KP, Sommariva A, et al. The current practice of cytoreductive surgery and HIPEC for colorectal peritoneal metastases: Results of a worldwide web-based survey of the Peritoneal Surface Oncology Group International (PSOGI). Eur J Surg Oncol. 2018;44(12):1942–8. https://doi.org/10.1016/j.ejso.2018.07.003.

    Article  CAS  PubMed  Google Scholar 

  2. Waite K, Youssef H. The role of neoadjuvant and adjuvant systemic chemotherapy with cytoreductive surgery and heated intraperitoneal chemotherapy for colorectal peritoneal metastases: a systematic review. Ann Surg Oncol. 2017;24(3):705–20. https://doi.org/10.1245/s10434-016-5712-3.

    Article  PubMed  Google Scholar 

  3. Rovers KP, Simkens GA, Punt CJ, van Dieren S, Tanis PJ, de Hingh IH. Perioperative systemic therapy for resectable colorectal peritoneal metastases: Sufficient evidence for its widespread use? A critical systematic review. Crit Rev Oncol Hematol. 2017;114:53–62. https://doi.org/10.1016/j.critrevonc.2017.03.028.

    Article  PubMed  Google Scholar 

  4. Cashin PH, Esquivel J, Larsen SG, et al. Perioperative chemotherapy in colorectal cancer with peritoneal metastases: A global propensity score matched study. eClinicalMedicine. 2023. https://doi.org/10.1016/j.eclinm.2022.101746.

    Article  PubMed  Google Scholar 

  5. Tonello M, Baratti D, Sammartino P, et al. Is systemic chemotherapy useful in patients treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for colorectal peritoneal metastases? A propensity score analysis. Annals Surg Oncol. 2023. https://doi.org/10.1245/s10434-023-14417-z.

    Article  Google Scholar 

Download references

Funding

No funds, grants, or other support were received.

Author information

Authors and Affiliations

Authors

Contributions

Conceptualization, writing: MT, AS. All authors have made substantial contributions to the conception of the study or the analysis and interpretation of data, drafting the work, or revising it critically for intellectual content. All authors have read and agreed to the published version of the manuscript.

Corresponding author

Correspondence to Marco Tonello MD, PhD.

Ethics declarations

Disclosure

The authors have no conflicts of interest or financial ties to disclose.

Ethics approval

This study was approved by the Ethics Committee of the Veneto Institute of Oncology IOV-IRCCS (No. 194/2019).

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tonello, M., Sommariva, A. ASO Author Reflections: Is Systemic Chemotherapy Useful in Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Colorectal Peritoneal Metastases? A Propensity Score Analysis. Ann Surg Oncol 31, 2008–2009 (2024). https://doi.org/10.1245/s10434-023-14468-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-023-14468-2

Navigation